Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors

Journal of Medicinal Chemistry
Chen-Xi WangZhi-Shu Huang

Abstract

DNA damage response (DDR) pathways are crucial for the survival of cancer cells and are attractive targets for cancer therapy. Bloom syndrome protein (BLM) is a DNA helicase that performs important roles in DDR pathways. Our previous study discovered an effective new BLM inhibitor with a quinazolinone scaffold by a screening assay. Herein, to better understand the structure-activity relationship (SAR) and biological roles of the BLM inhibitor, a series of new derivatives were designed, synthesized, and evaluated based on this scaffold. Among them, compound 9h exhibited nanomolar inhibitory activity and binding affinity for BLM. 9h could effectively disrupt BLM recruitment to DNA in cells. Furthermore, 9h inhibited the proliferation of the colorectal cell line HCT116 by significantly triggering DNA damage in the telomere region and inducing apoptosis, especially in combination with a poly (ADP-ribose) polymerase (PARP) inhibitor. This result suggested a synthetic lethal effect between the BLM and PARP inhibitors in DDR pathways.

References

Oct 29, 1999·Genes & Development·A J PierceM Jasin
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·J K KarowI D Hickson
Jul 4, 2001·Nucleic Acids Research·P MohagheghI D Hickson
Feb 21, 2002·The Journal of Biological Chemistry·Emanuelle PascoloAndreas Schnapp
Jul 3, 2007·Nature Structural & Molecular Biology·Sally L DaviesIan D Hickson
Nov 16, 2007·Genes & Development·Dmitry V BugreevAlexander V Mazin
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
Jul 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan Ashworth
Oct 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amitabh V NimonkarStephen C Kowalczykowski
Apr 10, 2009·Journal of Medicinal Chemistry·Jia-Heng TanLian-Quan Gu
May 15, 2009·Cell Cycle·Benjamin J MoellerWadih Arap
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Mar 11, 2010·Molecular Cancer Research : MCR·Kenza Lahkim Bennani-BelhajMounira Amor-Guéret
May 5, 2010·Cold Spring Harbor Protocols·Stephen T Smale
Feb 18, 2011·Genes & Development·Amitabh V NimonkarStephen C Kowalczykowski
Aug 25, 2012·Nature Reviews. Cancer·Peter Bouwman, Jos Jonkers
Nov 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hamed Mirzaei, Kristina H Schmidt
Dec 27, 2012·Molecular Biology Reports·Sarallah Rezazadeh
Jan 29, 2013·Chemistry & Biology·Giang Huong NguyenIan D Hickson
Mar 13, 2014·Annual Review of Biochemistry·Deborah L CroteauVilhelm A Bohr
Jun 4, 2014·Journal of Medicinal Chemistry·Bingliang Fang
Feb 25, 2015·Nature Reviews. Cancer·Laurence H PearlFrances M G Pearl
Jul 1, 2015·Nature Reviews. Clinical Oncology·Dörthe Schaue, William H McBride
Nov 23, 2015·Molecular Cell·Mark J O'Connor
Dec 17, 2015·Nature Reviews. Cancer·Penny A JeggoAntony M Carr
Dec 19, 2015·Nature Reviews. Cancer·Wynand P RoosBernd Kaina
Aug 9, 2016·Bio-protocol·Ilgen Mender, Jerry W Shay
Sep 26, 2017·Oncology Letters·Xiaosong QianXiaodong Zhang
Dec 6, 2018·Journal of the American Chemical Society·Zhou-Li HuangZhi-Shu Huang
Apr 3, 2019·Journal of Clinical Medicine·Man Yee T KeungJaydutt V Vadgama
Feb 6, 2020·Chemical Communications : Chem Comm·Hisae Tateishi-Karimata, Naoki Sugimoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis